Literature DB >> 8846792

The cellular factor TRP-185 regulates RNA polymerase II binding to HIV-1 TAR RNA.

F Wu-Baer1, W S Lane, R B Gaynor.   

Abstract

Activation of HIV-1 gene expression by the transactivator Tat is dependent on an RNA regulatory element located downstream of the transcription initiation site known as TAR. To characterize cellular factors that bind to TAR RNA and are involved in the regulation of HIV-1 transcription, HeLa nuclear extract was fractionated and RNA gel-retardation analysis was performed. This analysis indicated that only two cellular factors, RNA polymerase II and the previously characterized TAR RNA loop binding protein TRP-185, were capable of binding specifically to TAR RNA. To elucidate the function of TRP-185, it was purified from HeLa nuclear extract, amino acid microsequence analysis was performed and a cDNA encoding TRP-185 was isolated. TRP-185 is a novel protein of 1621 amino acids which contains a leucine zipper and potentially a novel RNA binding motif. In gel-retardation assays, the binding of both recombinant TRP-185 and RNA polymerase II was dependent on the presence of an additional group of proteins designated cellular cofactors. Both the TAR RNA loop and bulge sequences were critical for RNA polymerase II binding, while TRP-185 binding was dependent only on TAR RNA loop sequences. Since binding of TRP-185 and RNA polymerase II to TAR RNA was found to be mutually exclusive, our results suggest that TRP-185 may function either alone or in conjunction with Tat to disengage RNA polymerase II which is stalled upon binding to nascently synthesized TAR RNA during transcriptional elongation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8846792      PMCID: PMC394719          DOI: 10.1002/j.1460-2075.1995.tb00288.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  70 in total

1.  Discontinuous movements of DNA and RNA in RNA polymerase accompany formation of a paused transcription complex.

Authors:  D Wang; T I Meier; C L Chan; G Feng; D N Lee; R Landick
Journal:  Cell       Date:  1995-05-05       Impact factor: 41.582

2.  HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation.

Authors:  M F Laspia; A P Rice; M B Mathews
Journal:  Cell       Date:  1989-10-20       Impact factor: 41.582

3.  Tat trans-activates the human immunodeficiency virus through a nascent RNA target.

Authors:  B Berkhout; R H Silverman; K T Jeang
Journal:  Cell       Date:  1989-10-20       Impact factor: 41.582

4.  Coupling between transcription termination and RNA polymerase inchworming.

Authors:  E Nudler; M Kashlev; V Nikiforov; A Goldfarb
Journal:  Cell       Date:  1995-05-05       Impact factor: 41.582

5.  Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro.

Authors:  C Dingwall; I Ernberg; M J Gait; S M Green; S Heaphy; J Karn; A D Lowe; M Singh; M A Skinner; R Valerio
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

6.  Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5' sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system.

Authors:  O Elroy-Stein; T R Fuerst; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

7.  The RNA element encoded by the trans-activation-responsive region of human immunodeficiency virus type 1 is functional when displaced downstream of the start of transcription.

Authors:  M J Churcher; A D Lowe; M J Gait; J Karn
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

8.  Rapid RNA polymerase genetics: one-day, no-column preparation of reconstituted recombinant Escherichia coli RNA polymerase.

Authors:  H Tang; K Severinov; A Goldfarb; R H Ebright
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

9.  Novel mechanism and factor for regulation by HIV-1 Tat.

Authors:  Q Zhou; P A Sharp
Journal:  EMBO J       Date:  1995-01-16       Impact factor: 11.598

View more
  17 in total

1.  In vitro selection identifies key determinants for loop-loop interactions: RNA aptamers selective for the TAR RNA element of HIV-1.

Authors:  F Ducongé; J J Toulmé
Journal:  RNA       Date:  1999-12       Impact factor: 4.942

2.  The spoU gene of Escherichia coli, the fourth gene of the spoT operon, is essential for tRNA (Gm18) 2'-O-methyltransferase activity.

Authors:  B C Persson; G Jäger; C Gustafsson
Journal:  Nucleic Acids Res       Date:  1997-10-15       Impact factor: 16.971

3.  Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages.

Authors:  Q Zhou; D Chen; E Pierstorff; K Luo
Journal:  EMBO J       Date:  1998-07-01       Impact factor: 11.598

4.  Sequential steps in Tat trans-activation of HIV-1 mediated through cellular DNA, RNA, and protein binding factors.

Authors:  A Gatignol; M Duarte; L Daviet; Y N Chang; K T Jeang
Journal:  Gene Expr       Date:  1996

5.  Purification of a Tat-associated kinase reveals a TFIIH complex that modulates HIV-1 transcription.

Authors:  L F García-Martínez; G Mavankal; J M Neveu; W S Lane; D Ivanov; R B Gaynor
Journal:  EMBO J       Date:  1997-05-15       Impact factor: 11.598

6.  Potentiation of human immunodeficiency virus type 1 Tat by human cellular proteins.

Authors:  M E Greenberg; D A Ostapenko; M B Mathews
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

7.  Inhibition of transcription by the TAR RNA of HIV-1 in a nuclear extract of HeLa cells.

Authors:  R Yamamoto; S Koseki; J Ohkawa; K Murakami; S Nishikawa; K Taira; P K Kumar
Journal:  Nucleic Acids Res       Date:  1997-09-01       Impact factor: 16.971

8.  Recognition of 5'-terminal TAR structure in human immunodeficiency virus-1 mRNA by eukaryotic translation initiation factor 2.

Authors:  Y Ben-Asouli; Y Banai; H Hauser; R Kaempfer
Journal:  Nucleic Acids Res       Date:  2000-02-15       Impact factor: 16.971

9.  Cell cycle-regulated transcription by the human immunodeficiency virus type 1 Tat transactivator.

Authors:  F Kashanchi; E T Agbottah; C A Pise-Masison; R Mahieux; J Duvall; A Kumar; J N Brady
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

10.  Casein kinase II is a selective target of HIV-1 transcriptional inhibitors.

Authors:  J W Critchfield; J E Coligan; T M Folks; S T Butera
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.